ORPHAN DRUG ACT

Bills and resolutions

Drug industry: 7-year exclusive marketing privilege for other companies due to simultaneous development (see S. 2772)

Lists

Rare disease organizations supporting additional funding for Orphan Drug Act, 27929 [2OC]

Remarks in Senate

Drug industry: 7-year marketing privilege for other companies due to simultaneous development (S. 2772), 21933 [15AU]

Funding, 27929 [2OC]

Texts of

S. 2772, amendments, 21934 [15AU]